Belagavi: KLES Dr. Prabhakar Kore Hospital & Medical Research Centre has achieved a landmark in cardiac care with the successful implantation of the TRIA Mitral Valve, the world’s first approved polymer heart valve.
The procedure was led by Dr. Mohan D. Gan, Head of the CVTS Department at JNMC Medical College and Senior Cardiothoracic Surgeon, marking the first such implant in India.
Developed by U.S.-based Foldax and manufactured in India by Dolphin Life Science, the TRIA valve provides new treatment options for patients, especially those suffering from rheumatic heart disease. Unlike traditional valves, it is designed for longer durability and reduces dependency on lifelong blood thinners.
“This innovation represents a new era in heart valve replacement — one where patients may receive a longer-lasting solution without the lifelong need for blood thinners,” said Dr. Gan, who is also trained to mentor other surgeons in implanting the valve.
The complex procedure was executed by a multidisciplinary cardiac team including Dr. Darshan, Dr. Gananjay Salve, Dr. Abhishek Prabhu, Dr. Parishwanath Patil, Dr. Ranajit Naik, and Dr. Sharanagouda Patil (Head of Cardiac Anaesthesia) along with senior cardiologists Dr. Sanjay Porwal and Dr. Suresh Patted.

Congratulating the team, Dr. Prabhakar Kore, Chairman of KLE Society, and Rtd Col Dr. Dayanand, Medical Director, said the achievement would greatly benefit patients across the region.
“With 2,000 beds, 30 advanced operating theaters, and over 300 consultants, KLES Hospital continues to blend cutting-edge infrastructure with compassionate care,” Dr. Dayanand added.
This successful implant places Belagavi on the global map of advanced cardiac care, giving new hope to patients in Southern Asia and beyond.





















